PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 702 of 767

Advanced search

🌍Oct 6, 2025Industrypowerfulmedical.comTier 1 · Company source

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

Powerful MedicalOriginal source

🌍Oct 6, 2025Industrypsomagen.comTier 1 · Company source

WHITE PAPER: Comparison of Illumina and Ultima Sequencing Platforms for 10x Genomics Single-Cell RNA Sequencing

PsomagenOriginal source

🇯🇵Oct 6, 2025Devicesolympus-global.comTier 1 · Company source

Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

Olympus MedicalOriginal source

🇺🇸Oct 6, 2025CRObioagilytix.comTier 2 · Direct publisher

The Difference Between Pharmacokinetics and Pharmacodynamics

BioAgilytixOriginal source

🇺🇰Oct 4, 2025Researchstemcells.cam.ac.ukTier 2 · Direct publisher

Bertie Göttgens joins Stem Cell Reports as a new Editorial Board member

Cambridge Stem Cell InstituteOriginal source

🌍Oct 2, 2025Industrymyriad.comTier 3 · Secondary coverage

Using Prostate Cancer Gene Testing to Guide Treatment Decisions: Insights as We Head into 2026

MyriadOriginal source

🇺🇸Oct 1, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

Riskgaming State of the Union

Lux CapitalOriginal source

🌍Oct 1, 2025Industrymyriad.comTier 3 · Secondary coverage

Addressing Provider Misconceptions in Ovarian Cancer Genetic Testing

MyriadOriginal source

🌍Oct 1, 2025Devicesdigitaldiagnostics.comTier 1 · Company source

AI Doctors Won’t Work For Free

IDx (Digital Diagnostics)Original source

🌍Oct 1, 2025Devicesdigitaldiagnostics.comTier 1 · Company source

Autonomous AI Helps SSM Health Improve Eye Screening, Boost Equity

IDx (Digital Diagnostics)Original source

🌍Sep 30, 2025Industrymeridianbioscience.comTier 1 · Company source

Rethinking Campylobacter: Fast, Accurate Diagnostics for Better GI Outcomes

Meridian BioscienceOriginal source

🇩🇪Sep 29, 2025Mediadzne.deTier 2 · Direct publisher

Joint Professorship for Susanne Wegmann at DZNE and Charité

DZNE (Neurodegenerative Diseases)Original source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

UP celebrates 2022 autumn graduates

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

Selection programmes closing on 30 June: Find out which and apply now

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

Kindness Matters: Join our 21 Days of Kindness Challenge

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

INVITATION: Women in Science Symposium 2022 – ‘Gender, Diversity and Inclusion: Water Unites Us’

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

UP set to host third annual virtual #ChooseUP Day

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

INVITATION: 5th Dr Sam Motsuenyane Annual Lecture

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

NOTICE: Annual General Meeting of the Convocation

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

#CybersecurityMonth: Do your part – be cyber smart

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

INVITATION: Colloquium on the New Language Policy for Higher Education

University of PretoriaOriginal source

🇿🇦Sep 26, 2025Researchup.ac.zaTier 2 · Direct publisher

UP’s Pre-University Academy prepares learners for tertiary studies. Apply by 20 January 2023

University of PretoriaOriginal source

🌍Sep 25, 2025Regulatoryaupam.orgTier 1 · Regulatory source

إطلاق الاتحاد السوري لمنتجي الأدوية: مكتب إقليمي للاتحاد العربي لتعزيز الأمن الدوائي

Arab Pharma ManufacturersOriginal source

🇺🇸Sep 24, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

The global future of wargaming in Lithuania

Lux CapitalOriginal source

🇺🇸Sep 24, 2025Devicesfoundationmedicine.comTier 1 · Company source

Demonstrating the Clinical Utility of Foundation Medicine’s High-Quality Tests and Proprietary Biomarkers - A Research Recap

Foundation MedicineOriginal source

🇺🇸Sep 24, 2025CROinvestor.medpace.comTier 2 · Direct publisher

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

MedpaceOriginal source

🌍Sep 23, 2025Industryzevra.comTier 1 · Company source

Changing The Course of NPC: Long-term Evidence for Disease Modification in a Heterogenous Population

Zevra TherapeuticsOriginal source

🌍Sep 23, 2025Industrydayonebio.comTier 3 · Secondary coverage

Kids With Brain Tumors Deserve Better

Mersana TherapeuticsOriginal source

🇺🇸Sep 22, 2025Researcharchventure.comTier 2 · Direct publisher

ARCH’s Seaport Therapeutics included on Fierce Biotech’s 2025 Fierce 15 list of companies redefining biotech

ARCH Venture PartnersOriginal source

🌍Sep 22, 2025Regulatoryaupam.orgTier 1 · Regulatory source

مناقشة اولية لملتقى الصناعات الصيدلانية العربية 2026

Arab Pharma ManufacturersOriginal source

🌍Sep 22, 2025Mediahealx.aiTier 2 · Direct publisher

Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences

HealxOriginal source

🇺🇸Sep 20, 2025Researcharchventure.comTier 2 · Direct publisher

ARCH-backed Dispatch Bio and Sironax named to Endpoints 11 list of most exciting startups in 2025

ARCH Venture PartnersOriginal source

🌍Sep 18, 2025Industryevidana.comTier 1 · Company source

Discover How the Dog Walking Bag Can Transform Your Dog Walks!

EvidanaOriginal source

🇺🇸Sep 17, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

Behind the scenes of our new scenario, Southwest Silicon

Lux CapitalOriginal source

🇺🇸Sep 17, 2025Researchnews.emory.eduTier 2 · Direct publisher

Emory will be tuition-free for students whose families earn $200,000 or less

Emory University School of MedicineOriginal source

🇺🇸Sep 15, 2025Industrybioreference.comTier 1 · Company source

Labcorp Completes Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses

BioReference LaboratoriesOriginal source

🇩🇪Sep 15, 2025Mediadzne.deTier 2 · Direct publisher

DZNE Launches Podcast “90 Milliarden” with Host Marco Schreyl

DZNE (Neurodegenerative Diseases)Original source

🇫🇷Sep 13, 2025Industryastraveus.comTier 1 · Company source

Orange County Bio: Astraveus “Bringing Cell Therapies Closer to Patients”

AstraveusOriginal source

🌍Sep 11, 2025Mediaprecisionformedicine.comTier 2 · Direct publisher

Nicholas Richardson, DO, MPH, Departs FDA and Joins Precision for Medicine as VP, Clinical Development

Precision for MedicineOriginal source

🇺🇸Sep 11, 2025Industrycapsida.comTier 1 · Company source

A Letter to the STXBP1 Community

Capsida BiotherapeuticsOriginal source

🇨🇭Sep 10, 2025Industryatinary.comTier 1 · Company source

Atinary Joins the AWS Partner Network

Atinary TechnologiesOriginal source

🇺🇸Sep 10, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

How compute and AI will create next-gen superapps

Lux CapitalOriginal source

🇺🇸Sep 8, 2025CDMOkbibiopharma.comTier 2 · Direct publisher

KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

KBI BiopharmaOriginal source

🌍Sep 6, 2025Devicesdigitaldiagnostics.comTier 1 · Company source

Banner Health Testing for Vision Loss Using New Artificial Intelligence System

IDx (Digital Diagnostics)Original source

🌍Sep 5, 2025Industrymyriad.comTier 3 · Secondary coverage

How Genomic Testing is Transforming Treatment Decisions in Intermediate-Risk Prostate Cancer

MyriadOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

50 Years After the Monoclonal Antibody Breakthrough: Why Precision Medicine Still Needs Reinventing

MyriadOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

Facing Fear, Finding Strength: Jodi’s Story of Genetic Testing and Prevention

MyriadOriginal source

🌍Sep 4, 2025Mediascience37.comTier 2 · Direct publisher

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

Science 37Original source

🇺🇸Sep 4, 2025Devicesaccuray.comTier 1 · Company source

World Radiotherapy Awareness Day: A Call to Action to Make Radiotherapy Understood and Accessible

AccurayOriginal source

🇩🇪Sep 4, 2025CDMOformycon.comTier 2 · Direct publisher

Enno Spillner im Interview mit Börsen Radio Network AG bei den Hamburger Investorentagen

FormyconOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

5 Ways a Women’s Genetic Testing Provider Should Align with Your Value-Based Care Goals

MyriadOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

Genetic Testing in the C-Suite: Five Things Health System Leaders Need to Know Now

MyriadOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

The Clinical Impact of Myriad Women’s Health on Hereditary Cancer Risk Assessment and Genetic Testing

MyriadOriginal source

🌍Sep 4, 2025Industrymyriad.comTier 3 · Secondary coverage

Modernizing Genetic Counseling in Women’s Health Programs: Enhancing Clinical Workflows While Reducing Provider Burden

MyriadOriginal source

🇩🇪Sep 4, 2025Mediadzne.deTier 2 · Direct publisher

Misdirected: Increased Dementia Risk Associated with Errors of the “Brain’s Compass”

DZNE (Neurodegenerative Diseases)Original source

🌍Sep 3, 2025Industryfidson.comTier 1 · Company source

Fidson Signs MOU with Japanese Firm at TICAD9

Fidson HealthcareOriginal source

🌍Sep 3, 2025Mediaperspectum.comTier 2 · Direct publisher

New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States

PerspectumOriginal source

🇺🇸Sep 3, 2025Researchpodcasters.spotify.comTier 3 · Secondary coverage

America’s degrowth lawyers need to learn from China

Lux CapitalOriginal source

🌍Sep 3, 2025Mediavalneva.comTier 2 · Direct publisher

Harnessing Human Potential to Power Vaccine Innovation

ValnevaOriginal source

🇺🇸Sep 3, 2025Researcharchventure.comTier 2 · Direct publisher

Five ARCH-backed companies and executives named to Fierce 50 list of those making a significant impact in the biopharma and healthcare industries

ARCH Venture PartnersOriginal source